Stille AB - Asset Resilience Ratio
Stille AB (STIL) has an Asset Resilience Ratio of 14.76% as of September 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read STIL total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2017)
This chart shows how Stille AB's Asset Resilience Ratio has changed over time. See STIL book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Stille AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Stille AB stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr13.27 Million | 14.76% |
| Total Liquid Assets | Skr13.27 Million | 14.76% |
Asset Resilience Insights
- Moderate Liquidity: Stille AB has 14.76% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Stille AB Industry Peers by Asset Resilience Ratio
Compare Stille AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for Stille AB (2013–2017)
The table below shows the annual Asset Resilience Ratio data for Stille AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | Skr0.00 ≈ $0.00 |
Skr92.34 Million ≈ $9.94 Million |
-- |
| 2016-12-31 | 0.00% | Skr0.00 ≈ $0.00 |
Skr80.42 Million ≈ $8.65 Million |
-- |
| 2015-12-31 | 3.89% | Skr2.71 Million ≈ $291.32K |
Skr69.51 Million ≈ $7.48 Million |
-1.49pp |
| 2014-12-31 | 5.39% | Skr3.00 Million ≈ $322.85K |
Skr55.69 Million ≈ $5.99 Million |
+1.14pp |
| 2013-12-31 | 4.24% | Skr2.65 Million ≈ $284.75K |
Skr62.34 Million ≈ $6.71 Million |
-- |
About Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascu… Read more